Home
>
National Drug Code (NDC)
>
INDOCIN
INDOCIN - 42211-102-40 - (indomethacin)
Drug Information of INDOCIN
| Product NDC: | 42211-102 |
| Proprietary Name: | INDOCIN |
| Non Proprietary Name: | indomethacin |
| Active Ingredient(s): | 50 mg/1 & nbsp; indomethacin |
| Administration Route(s): | RECTAL |
| Dosage Form(s): | SUPPOSITORY |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of INDOCIN
| Product NDC: | 42211-102 |
| Labeler Name: | Iroko Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA073314 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20081103 |
Package Information of INDOCIN
| Package NDC: | 42211-102-40 |
| Package Description: | 2 SUPPOSITORY in 1 BOX (42211-102-40) |
NDC Information of INDOCIN
| NDC Code | 42211-102-40 |
| Proprietary Name | INDOCIN |
| Package Description | 2 SUPPOSITORY in 1 BOX (42211-102-40) |
| Product NDC | 42211-102 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | indomethacin |
| Dosage Form Name | SUPPOSITORY |
| Route Name | RECTAL |
| Start Marketing Date | 20081103 |
| Marketing Category Name | ANDA |
| Labeler Name | Iroko Pharmaceuticals, LLC |
| Substance Name | INDOMETHACIN |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
